 "Metabolix sells biopolymer assets to CJ CheilJedang")
Metabolix Inc has sold its biopolymer intellectual property and certain laboratory equipment to South Korea’s CJ CheilJedang Corporation for $ 10 million. Completion of the transaction is subject to the negotiation of definitive agreements and other customary conditions.
Under the definitive agreements, Metabolix will transfer to CJ a portfolio of intellectual property (IP) including the platform microbial strains used to produce the company's fermentation based products, as well as patent rights covering the production and use of PHA (polyhydroxyalkanoate) biopolymers. CJ will also acquire certain laboratory equipment associated with the biopolymers business. The arrangement is also expected to include a sublease to CJ of a portion of Metabolix’s Woburn (Massachusetts) facility.
"We believe this transaction will help put the Company on a more stable footing and enable us to move forward with our plan to make Yield10 Bioscience our core business. We are excited about our new direction and look forward to focusing our efforts on developing disruptive technologies for step-change improvements in crop yield," said Joseph Shaulson, president and CEO of Metabolix.
Metabolix announced its new strategic direction in July and anticipates a staff of approximately 20 people with an annual net cash burn rate in the range of $5 million once it has completed its transition and related restructuring. Consistent with this new strategy, the company plans to rebrand itself as Yield10 Bioscience in the coming months.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%